HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Till Sebastian Clauditz Selected Research

src-Family Kinases

1/2021Analyzing tyrosine kinase activity in head and neck cancer by functional kinomics: Identification of hyperactivated Src family kinases as prognostic markers and potential targets.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Till Sebastian Clauditz Research Topics

Disease

16Neoplasms (Cancer)
06/2021 - 10/2012
5Carcinoma (Carcinomatosis)
06/2021 - 08/2011
4Squamous Cell Carcinoma of Head and Neck
06/2020 - 10/2014
4Microsatellite Instability
06/2020 - 01/2020
3Prostatic Neoplasms (Prostate Cancer)
06/2021 - 06/2018
2Colorectal Neoplasms (Colorectal Cancer)
06/2021 - 10/2012
2Turcot syndrome
03/2021 - 01/2020
2Lung Neoplasms (Lung Cancer)
01/2018 - 10/2012
1Merkel Cell Carcinoma
06/2021
1Breast Neoplasms (Breast Cancer)
06/2021
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
06/2021
1Anaplastic Thyroid Carcinoma
06/2021
1Lobular Carcinoma
06/2021
1Renal Cell Carcinoma (Grawitz Tumor)
06/2021
1Lymphatic Metastasis
06/2021
1Gastroesophageal Reflux (GERD)
03/2021
1Seminoma
03/2021
1Hypercalcemia (Milk Alkali Syndrome)
02/2021
1Diarrhea
02/2021
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2021
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2018
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
09/2014
1Leiomyosarcoma
01/2013
1Liposarcoma
01/2013
1Hemangiosarcoma (Angiosarcoma)
09/2012
1Osteoarthritis
01/2006

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
06/2021 - 10/2012
5Immune Checkpoint InhibitorsIBA
03/2021 - 01/2020
3Phosphotransferases (Kinase)IBA
01/2021 - 11/2013
3Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2017
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
09/2014 - 09/2012
2ErbB Receptors (EGF Receptor)IBA
01/2019 - 10/2012
2DNA (Deoxyribonucleic Acid)IBA
01/2013 - 10/2012
1Cadherins (E-Cadherin)IBA
06/2021
1Mismatch Repair Endonuclease PMS2IBA
03/2021
1PENTAIBA
03/2021
1Proton Pump InhibitorsIBA
03/2021
1CalciumIBA
02/2021
1Parathyroid Hormone (Parathormone)IBA
02/2021
1Peptides (Polypeptides)IBA
02/2021
1Octreotide (Sandostatin)FDA LinkGeneric
02/2021
1src-Family KinasesIBA
01/2021
1Tyrosine (L-Tyrosine)FDA Link
01/2021
1Protein Kinases (Protein Kinase)IBA
01/2021
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2021
1Biological ProductsIBA
06/2020
1MutL Protein Homolog 1IBA
01/2020
1AntibodiesIBA
01/2020
1SurvivinIBA
01/2019
1Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
01/2018
1tyrosine receptor (receptor, tyrosine)IBA
01/2018
1Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA
10/2014
1Transcription Factors (Transcription Factor)IBA
01/2013
1Epidermal Growth Factor (EGF)IBA
10/2012
1human ERBB2 proteinIBA
08/2011
1Cartilage Oligomeric Matrix ProteinIBA
01/2006

Therapy/Procedure

6Therapeutics
01/2020 - 10/2012
1Cesarean Section (Caesarean Section)
02/2021
1Radiotherapy
06/2020